Fleeting Victories: COVID-19 and the Temporary Improvements in Asthma Care Behaviours

Overview

Journal Lancet Reg Health Eur

Specialty Health Services

Date 2024 Jul 5

PMID 38966205

Authors

Rama Vancheeswaran

Meera Mehta

Affiliations

Soon will be listed here.

References

Ritz T, Meuret A, Trueba A, Fritzsche A, von Leupoldt A . Psychosocial factors and behavioral medicine interventions in asthma. J Consult Clin Psychol. 2012; 81(2):231-50. PMC: 6019133. DOI: 10.1037/a0030187. View

Hazan G, Fox C, Mok H, Haspel J . Age-dependent rebound in asthma exacerbations after COVID-19 lockdown. J Allergy Clin Immunol Glob. 2022; 1(4):314-318. PMC: 9364738. DOI: 10.1016/j.jacig.2022.06.001. View

Gupta R, Mukherjee M, Sheikh A, Strachan D . Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England. Thorax. 2018; 73(8):706-712. PMC: 6204968. DOI: 10.1136/thoraxjnl-2017-210714. View

Jones R, Nicholls A, Browning D, Bakerly N, Woodcock A, Vestbo J . Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies. ERJ Open Res. 2020; 6(1). PMC: 7073415. DOI: 10.1183/23120541.00193-2019. View

Mukherjee M, Okusi C, Jamie G, Byford R, Ferreira F, Agarwal U . Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care database. Lancet Reg Health Eur. 2024; 42:100938. PMC: 11153226. DOI: 10.1016/j.lanepe.2024.100938. View

Barrett R, Barrett R . Asthma and COPD medicines prescription-claims: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020). Expert Rev Respir Med. 2021; 15(12):1605-1612. DOI: 10.1080/17476348.2022.1985470. View

Shah S, Quint J, Sheikh A . Impact of COVID-19 pandemic on asthma exacerbations: Retrospective cohort study of over 500,000 patients in a national English primary care database. Lancet Reg Health Eur. 2022; 19:100428. PMC: 9213032. DOI: 10.1016/j.lanepe.2022.100428. View

Dougherty R, Fahy J . Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin Exp Allergy. 2009; 39(2):193-202. PMC: 2730743. DOI: 10.1111/j.1365-2222.2008.03157.x. View

Tydeman F, Pfeffer P, Vivaldi G, Holt H, Talaei M, Jolliffe D . Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK). Thorax. 2022; 78(8):752-759. PMC: 10359556. DOI: 10.1136/thorax-2022-219591. View

10.

Ho T, Shahzad A, Jones A, Raghavan N, Loeb M, Johnston N . Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus. Thorax. 2023; 78(12):1248-1253. PMC: 10715522. DOI: 10.1136/thorax-2022-219957. View